We're covering Eli Lilly’s Phase 3 trial for their new weight loss pill orforglipron. Seeking commentary, including: (1) How is this medication different from other GLP-1RAs as far as its formulation and administration? (2) How does it compare when it comes to weight loss effectiveness? (3) What advantages might it have over other GLP-1RAs? (4) Any disadvantages beyond less potential weight loss? (5) When can we expect it to become available? (6) How will it likely compare as far as cost? (7) Any other important points that consumers need to know about this medication?

Looking for Dermatologists to Discuss Vitamin B3 and Skin Cancer Risk

Published on: 9/25/2025

Cardiologist: Heart attack causes in younger patients

Published on: 9/24/2025

Cardiologist: Heart attack causes in younger patients

Published on: 9/24/2025

Endocrinologist: Type 2 diabetes risk increased 4x by cannabis use

Published on: 9/24/2025

Endocrinologist: Type 2 diabetes risk increased 4x by cannabis use

Published on: 9/24/2025

20 Pitching Tips to Win Media Coverage in 2025

Real Pitches That Landed Coverage on WSJ, Forbes & More…

Top 12 AI Tools For Better Media Pitching

How to Pitch a Journo Request? (A Complete Beginner's Guide)